EP3470421
Mótlyf fyrir blendings IL-1 viðtaka af gerð I
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.7.2011EP published:
7.6.2023EP application number:
18191564.6
EP translation filed:
17.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
28.7.2031Expiry date:
28.7.2026Next due date:
31.7.2026
Title in English:
CHIMERIC IL-1 RECEPTOR TYPE I ANTAGONISTSLanguage of the patent:
English
Timeline
Today
29.7.2011EP application
7.6.2023EP Publication
17.7.2023Translation submitted
15.8.2023Registration published
28.7.2026Expires
Owner
Name:
Buzzard Pharmaceuticals ABAddress:
Skeppsbron 16, 111 30 Stockholm, SE
Inventor
Name:
BARNES, Thomas M.Address:
Cambridge, MA Massachusetts 02142, US
Name:
HOU, JinzhaoAddress:
Cambridge, MA Massachusetts 02142, US
Name:
KING, Bracken M.Address:
Cambridge, MA Massachusetts 02142, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
36879910 PDate:
29.7.2010Country:
US
Number:
201161436178 PDate:
25.1.2011Country:
US
Number:
201161436184 PDate:
25.1.2011Country:
US
Number:
201161493966 PDate:
6.6.2011Country:
US
Number:
201161493967 PDate:
6.6.2011Country:
US
Classification
Categories:
C07K 14/545, A61P 19/02, A61K 38/20
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 26.7.2023
Expires: 28.7.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 30.7.2024
Expires: 28.7.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 23.7.2025
Expires: 28.7.2026
Payer: iPify